Dan Zhao

QOL-26. A RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF VORASIDENIB VS PLACEBO IN PATIENTS WITH MUTANT <i>IDH1/2</i>DIFFUSE GLIOMA (INDIGO): ANALYSIS OF HEALTH-RELATED QUALITY OF LIFE, NEUROCOGNITION AND SEIZURES

Katherine B. Peters, Ingo K. Mellinghoff, Martin J. van den Bent et al. · Neuro-Oncology · 2023 · 20 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

LTBK-06. IMPACT OF VORASIDENIB TREATMENT ON MUTANT <i>IDH1</i> OR <i>IDH2</i> DIFFUSE GLIOMA TUMOR GROWTH RATE: RESULTS FROM THE RANDOMIZED, DOUBLE-BLIND, PHASE 3 INDIGO STUDY

Patrick Y. Wen, Ingo K. Mellinghoff, Martin J. van den Bent et al. · Neuro-Oncology · 2023 · 18 citations · Full text

Medicine, Neurology, Oncology +17

Double-target neural circuit-magnetic stimulation improves motor function in spinal cord injury by attenuating astrocyte activation

Qing Xie, Dongsheng Xu, Dan Zhao et al. · Neural Regeneration Research · 2022 · 13 citations · Full text

Medicine, Neurology, Neuroscience +17

INDIGO: A global, randomized, double-blinded, phase 3 study of vorasidenib versus placebo in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation.

Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal et al. · Journal of Clinical Oncology · 2023 · 10 citations

Medicine, Oncology, Pharmacology +13

Neurological activation during verbal fluency task and resting-state functional connectivity abnormalities in obsessive-compulsive disorder: a functional near-infrared spectroscopy study

Yongjun Qiao, Xiaohui Song, Yan Jin et al. · Frontiers in Psychiatry · 2024 · 10 citations · Full text

Life Sciences, Neuroscience, Psychiatry +16